Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new way to use TMS, a treatment for depression, by using a virtual reality system to help guide the treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I take medication that doesn't allow me to have TMS treatment.My health is stable; no recent issues found in exams or tests.I did not improve after ECT, VNS, or DBS treatments.My medication doses have been stable for 4 weeks and I agree to keep them the same during the study.I am not pregnant, breastfeeding, and I use birth control or do not plan to become pregnant.I am unable to understand or make decisions about my treatment.My depression hasn't improved after trying two or more treatments and TMS.I have a condition that affects my nerves or muscles.You have had problems with drugs or alcohol in the past six months (or two months if it was not as severe). You have also used drugs through injections in the past.I haven't taken MAOI drugs in the last month.You are currently feeling extremely sad and have thoughts of hurting yourself or a plan to do so.I am taking medication that could increase my risk of seizures.You experience extreme fear or discomfort in small, enclosed spaces.You have received ketamine treatment within the past 6 months.I have not been diagnosed with a psychotic disorder or severe eating disorder in the past year.I have been diagnosed with major depression.
- Group 1: virtual neuro-navigation
- Group 2: on-line neuro-navigation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the clinical trial accept individuals aged 60 and over?
"Within the parameters of 18-60 years old, this trial is open to suitable candidates."
To what extent could Neuro-navigated Transcranial Magnetic Stimulation (TMS) be a hazard to patients?
"Our team at Power has deemed the safety profile of Neuro-navigated Transcranial magnetic stimulation (TMS) to be a score 1, as data backing up its security and effectiveness is only preliminary."
What is the aggregate amount of individuals taking part in this experiment?
"Affirmative. According to clinicaltrials.gov, this scientific trial is actively recruiting patients since its initial posting on July 1st 2021 and most recent update on April 13th 2022. Currently the research team seeks 12 participants from a single medical centre."
Are there currently openings for participants in this investigation?
"Affirmative. Data hosted on clinicaltrials.gov verifies that this medical research, which was initially published on the first of July 2021, is actively searching for participants. For the trial to be successful 12 people must enroll in the single location it has been assigned to."
Who is eligible to join this clinical research?
"To be considered for this clinical trial, participants must have unipolar depression and reside between the ages of 18 to 60. A maximum of 12 people are being enrolled at this time."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Average response time
- < 1 Day
Most responsive sites:
- Columbia Docs: < 24 hours
Share this study with friends
Copy Link
Messenger